To confirm the shBRAF of the cell death effects, we co‐treated selective BRAF inhibitor vemurafenib and found that vemurafenib treatment aggravated STS‐induced death in 8505C cells exposed to STS (Figure 2F,I). Here, BRAF is linked to telomere syndrome.